Levodopa in Parkinson’s Disease
✍ Scribed by Dr M. Gustavo Murer, Rita Raisman-Vozari, Oscar Gershanik
- Book ID
- 119925120
- Publisher
- Springer International Publishing AG
- Year
- 1999
- Tongue
- English
- Weight
- 181 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0114-5916
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Three patients with Parlcinson's disease, optimally treated with levodopdcabidopa (LDKD) tablets, but experiencing severe motor fluctuations, were administered a solution of levodopd carbidopalascorbic acid (LCAS) orally at intervals ranging from 30 to 60 minutes. Patients were rated half-hourly to
## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks